Why is Nath Bio-Genes falling/rising?

As of 29-Aug, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at 170.75, down by 3.25 or 1.87%. The stock has been underperforming, having lost 4.07% over the past week and 6.31% over the past month. It has also consistently fallen for the last four days, with a significant drop in returns. Despite a rise in delivery volume by 121.05% against the 5-day average, the stock is trading below its moving averages across various time frames, indicating weak momentum. The company's return on equity stands at a low 6%, and while it trades at a discount compared to peers, its long-term fundamentals show a negative growth trend in operating profits, contributing to the stock's recent downward movement.
In the broader market context, Nath Bio-Genes has underperformed compared to the benchmark Sensex, which has seen a decline of only 1.84% over the past week. The stock's year-to-date performance is notably poor, with a drop of 9.30%, contrasting sharply with the Sensex's gain of 2.14%. This consistent underperformance against the benchmark over the past three years, coupled with a decrease in institutional investor participation, further exacerbates the stock's challenges. The overall market sentiment appears to be unfavorable for Nath Bio-Genes, as it has generated negative returns in comparison to broader market indices, indicating a lack of confidence among investors.